Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say
The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%.
Congressional candidate physician sues hospital and doctor for death of father
Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services.
Diabetes reduces survival after SAVR, but not TAVR
"TAVR has been associated with better valve hemodynamics and a lower risk of structural valve deterioration over time compared with SAVR," researchers wrote. "This benefit may be particularly relevant for diabetes patients who face higher risks of vascular complications."
DEA wants to permanently anchor some COVID-era prescription regulations
The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17.
Brain changes related to Huntington's evident on imaging decades before symptoms emerge
Experts hope their findings offer valuable insights that one day lead to improved interventions aimed at preserving brain function in patients with Huntington's.

The blood clot plot continues: Countries suspend use of AstraZeneca COVID-19 vaccine in younger adults

The ongoing saga continues. Both Germany and Canada have now limited the use of the AstraZeneca vaccine among younger adults.

Beta-blockers are inferior to other antihypertensive treatment options, new research confirms

The authors tracked outcomes from more than 386,000 patients treated from 2001 to 2018, sharing their findings in Hypertension.

New and improved: Hospital updates AFib ablation protocols, improves efficiency

“Value can be defined as delivered care divided by cost,” the specialists wrote. “Ideally, each patient receives the same good quality of care in an equitable, timely way.”

Study confirms COVID-19 vaccines are effective

A new study has confirmed vaccines from Pfizer-BioNTech and Moderna are effective at preventing symptomatic COVID-19 cases.

TMVR safe and effective for kidney transplant recipients

One important detail, however, was that acute kidney injury was more common for kidney transplant recipients. The researchers listed numerous potential explanations for this trend.

Working long hours increases the likelihood of a second heart attack

The analysis, published in the Journal of the American College of Cardiology, tracked nearly 1,000 patients treated for their first myocardial infarction from November 1995 to October 1997.

‘A new treatment option’: FDA approves Harmony TPV, says it could delay the need for certain surgeries

The solution’s approval was based on 30-day and six-month data from a clinical study focused on mortality and hemodynamic function.

FDA approves Zealand Pharma’s new treatment for severe hypoglycemia

The injection, being marketed as Zegalogue, will be made available in an auto injector or a prefilled syringe.

Clinical

Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

Congressional candidate physician sues hospital and doctor for death of father

Diabetes reduces survival after SAVR, but not TAVR

DEA wants to permanently anchor some COVID-era prescription regulations

Brain changes related to Huntington's evident on imaging decades before symptoms emerge